Evidence map›Paper›PMID 40630804›Full record

ArticleTelemedicine reports2025

Cost-Effectiveness Analysis of Adding Telerehabilitation to Standard Care for Ankle Sprains Compared with Standard Care Alone.

Juan Figueroa-García, Víctor Marcial Granados-García, Juan Carlos H Hernández-Rivera, David Rojano-Mejía

Abstract read
In one paragraph

Article in Telemedicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan Figueroa-GarcíaUnidad de Medicina Familiar N. 26, Órgano de Operación Administrativa Desconcentrada de la Ciudad de México Sur, Instituto Mexicano del Seguro Social, Ciudad de México, México.ORCID https://orcid.org/0000-0001-5479-4780
Víctor Marcial Granados-GarcíaUnidad de Investigación Epidemiológica y en Servicios de Salud, Área Envejecimiento, Instituto Mexicano del Seguro Social, Ciudad de México, México.ORCID https://orcid.org/0000-0002-9075-576X
Juan Carlos H Hernández-RiveraUnidad de Investigación Médica en Enfermedades Nefrológicas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, México.
David Rojano-MejíaCoordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Ciudad de México, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ankle sprain (AS) is a common musculoskeletal injury. While telerehabilitation is an effective treatment for various musculoskeletal conditions, evidence on its cost-effectiveness for AS is lacking. Methods: A cost-effectiveness study was conducted through a 4-week randomized controlled trial in individuals with AS. The control group ( Results: At 4 weeks, the intervention group showed a gain of 78 points in functionality for FAAM-ADL and 80.2 points for FAAM-sports, while the control group scored 69.1 and 61.6, respectively. When the costs of work incapacity were considered, the incremental cost-effectiveness ratio (ICER) of adding telerehabilitation per point gained in FAAM-ADL functionality was US$ -14.4 and US$ -8.5 for FAAM-sports. When work incapacity costs were excluded, the ICER was US$ -0.7 and US$ -0.4, respectively. Conclusions: Adding telerehabilitation to standard care for AS was cost-saving, achieving greater effectiveness at a lower cost. This is more evident when direct costs are considered together with the costs of work incapacity.

Indexed as

ankle sprainclinical trialcost-effectivenessrehabilitationtelehealthtelerehabilitation

Identifiers

PMID40630804
PMCPMC12235126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.